White Rose Pharma Chem Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 2.17 M
- Company Age 25 Year, 4 Months
- Open Charges ₹ 1.00 M
About White Rose Pharma Chem
White Rose Pharma Chem Limited (WRPCL) is a Public Limited Indian Non-Government Company incorporated in India on 01 October 1999 and has a history of 25 years and four months. Its registered office is in Punjab, Punjab.
The Company is engaged in the Chemicals Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.17 M.
The company currently has active open charges totaling ₹1.00 M.
Gurmesh Kumar and Chuni Lal serve as directors at the Company.
Company Details
-
LocationPunjab, Punjab
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239PB1999PLC022973
-
Company No.
022973
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
01 Oct 1999
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at White Rose Pharma Chem?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chuni Lal
|
Managing Director | 05-Oct-1999 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Gurmesh Kumar
|
Director | 10-Nov-1999 | Current |
Financial Performance of White Rose Pharma Chem.
Enhance accessibility to White Rose Pharma Chem's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of White Rose Pharma Chem?
Unlock access to White Rose Pharma Chem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Saichem Laboratories Pvt LimitedGurmesh Kumar and Chuni Lal are mutual person
-
White Rose Estate And Investment Private Limited
Gurmesh Kumar and Chuni Lal are mutual person
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of Patiala : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Sep 2001 | State Bank Of Patiala | ₹1.00 M | Open |
How Many Employees Work at White Rose Pharma Chem?
Unlock and access historical data on people associated with White Rose Pharma Chem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of White Rose Pharma Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped White Rose Pharma Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.